세계의 반추동물용 백신 시장 규모, 점유율 및 동향 분석 보고서 : 동물 유형별, 백신 유형별, 투여 경로별, 적응증별, 지역별 전망 및 예측(2024-2031년)

The Global Ruminant Vaccines Market size is expected to reach $5.7 billion by 2031, rising at a market growth of 6.7% CAGR during the forecast period.

BVD is a highly economically significant disease in cattle, causing substantial losses to the livestock industry worldwide. Effective vaccinations to prevent and control BVD are in high demand due to the economic burden of outbreaks. Consequently, the BVD infection segment would acquire nearly, 30% market share by2031. The disease reduces productivity, including decreased milk production, weight loss, reduced reproductive performance, increased veterinary costs, and increased susceptibility to secondary infections.

The demand for foods high in protein, such as meat, milk, and dairy products, is rising along with the world's population. Additionally, urbanization trends often lead to changes in dietary habits. This creates a substantial market opportunity for ruminant vaccines, as producers strive to comply with regulations and ensure the health and safety of their animals. Thus, the increasing demand for livestock products drives the market's growth. Additionally, the emergence and spread of infectious illnesses are made possible by the intensification of livestock production systems, which is a result of population growth and an increase in the demand for animal products. Therefore, the growing prevalence of infectious diseases is propelling the growth of the market.

However, Vaccination programs require significant financial investment from farmers, particularly those operating on small or medium scales with limited resources. The cost of purchasing vaccines and associated expenses such as storage, administration, and veterinary services can strain farm budgets. Also, vaccines' production, distribution, and storage entail logistical challenges that can contribute to their high cost. Therefore, the high cost of vaccines Is impeding the market's growth.

The COVID-19 pandemic disrupted global supply chains, affecting the production and distribution of veterinary vaccines, including vaccines. Restrictions on movement, lockdown measures, and transportation disruptions led to delays in vaccine manufacturing, shortages of raw materials, and logistical challenges in vaccine distribution. Similarly, healthcare resources and attention primarily focused on combating COVID-19 during the pandemic. These changes had implications for disease transmission dynamics and vaccination strategies in ruminant populations, influencing vaccine demand. Thus, the COVID-19 pandemic had a negative impact on the market.

By Animal Type Analysis

Based on animal type, the market is divided into cattle and sheep & goats. The sheep & goats segment procured a 14.95% revenue share in the market in 2023. The sheep and goat industry are experiencing growth globally, driven by increasing demand for meat, milk, and fiber products. There is an increasing focus on high-quality, sustainable animal production as the population expands and customer demands change. This production growth creates a greater need for disease prevention and control measures, including vaccination, to ensure the health and productivity of sheep and goat populations.

By Vaccines Type Analysis

On the basis of vaccines type, the market is segmented into modified/ attenuated live, inactivated (killed), and others. In 2023, the inactivated (killed) segment attained a 34.15% revenue share in the market. Inactivated vaccines are generally more stable and have longer shelf lives. Inactivated vaccines' stability and shelf life make them suitable for use in remote or resource-limited areas.

By Route of Administration Analysis

By route of administration, the market is bifurcated into injectable and intranasal. The intranasal segment procured a 5.68% revenue share in the market in 2023. Intranasal vaccines offer a non-invasive route of administration, as they are administered through the nasal passages rather than by injection. This non-invasive approach reduces animal stress and discomfort during vaccination, making intranasal vaccines particularly suitable for use in ruminants that may be difficult to handle or restrain for injection.

By Indication Analysis

Based on indication, the market is categorized into BVD infection, bovine respiratory diseases (BRD), leptospirosis, clostridial diseases, diarrhea/ scours, FMD, and others. The clostridial diseases segment attained a 16.76% revenue share in the market in 2023. Clostridial diseases, such as blacklegs (Clostridium chauvoei), malignant edema (C. septicum), tetanus (C. tetani), and enterotoxemia (C. perfringens types C and D), can cause severe and often fatal infections in livestock. The devastating impact of clostridial diseases on animal health drives demand for effective vaccines to prevent disease outbreaks and reduce mortality rates.

By Regional Analysis

Region-wise, the market is analyzed across North America, Europe, Asia Pacific, and LAMEA. The North America region witnessed 36% revenue share in the ruminant vaccines market in 2023. North American livestock producers prioritize animal health and welfare to maintain the quality and integrity of their products. By investing in vaccination programs and disease management strategies, North American producers aim to ensure the well-being of their livestock and meet consumer expectations for safe and wholesome meat and dairy products.

Recent Strategies Deployed in the Market

Mar-2024: Boehringer Ingelheim International GmbH came into partnership with Square Pharmaceuticals, which manufactures and markets pharmaceuticals and animal health products, to launch Aftovaxpur, an advanced FMD vaccine for ruminants in Bangladesh. Through this partnership, the company will enhance the safety and reliability of vaccines to combat this outbreak.

Aug-2023: Zoetis, Inc. launched Vetscan Mastigram+, a rapid on-farm mastitis diagnostic, in several markets across Europe. This product launch will help to prudent use of antimicrobials and expand the company's portfolio.

Jun-2023: Zoetis, Inc. launched Protivity, the first in-class modified live vaccine approved to protect healthy beef and dairy calves against respiratory disease caused by M. bovis infection in the EU. This will protect healthy beef and dairy calves against respiratory disease caused by Mycoplasma bovis (M. bovis).

Dec-2022: Ceva Sante Animale acquired Zoovet, a company specializing in the production and marketing of animal health products, and Biotecnofe, a biotech start-up developing innovative products to be distributed by Zoovet, to increase our footprint in Latin America. Through this acquisition, the company will provide solutions that help farmers keep their animals healthy.

Sep-2022: Boehringer Ingelheim International GmbH added Fencovis, the first calf scour vaccine with a prevention claims against E. coli F5 and bovine rotavirus, to its vaccine portfolio. Through this launch, the company will provide passive immunity to calves through the cows' maternal colostrum.

List of Key Companies Profiled

• Boehringer Ingelheim International GmbH
• Zoetis, Inc.
• Merck & Co., Inc.
• Bimeda, Inc.
• Elanco Animal Health, Inc.
• Virbac
• Ceva Sante Animale
• CZ Vaccines S.A.U. (Zendal Health S.A.)
• Indian Immunologicals Ltd. (National Dairy Development Board)
• Vaxxinova International BV (EW Group)

Global Ruminant Vaccines Market Report Segmentation

By Animal Type

• Cattle
• Sheep & Goats

By Vaccines Type

• Modified/ Attenuated Live
• Inactivated (Killed)
• Others

By Route of Administration

• Injectable
• Intranasal

By Indication

• Bovine Respiratory Diseases (BRD)
• Diarrhea/ Scours
• FMD
• Clostridial Diseases
• Leptospirosis
• BVD Infection
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Table of Contents

Chapter 1.Market Scope & Methodology

• 1.1Market Definition
• 1.2Objectives
• 1.3Market Scope
• 1.4Segmentation
  • 1.4.1Global Ruminant Vaccines Market, by Animal Type
  • 1.4.2Global Ruminant Vaccines Market, by Vaccines Type
  • 1.4.3Global Ruminant Vaccines Market, by Route of Administration
  • 1.4.4Global Ruminant Vaccines Market, by Indication
  • 1.4.5Global Ruminant Vaccines Market, by Geography
• 1.5Methodology for the research

Chapter 2.Market at a Glance

• 2.1Key Highlights

Chapter 3.Market Overview

• 3.1Introduction
  • 3.1.1Overview
    • 3.1.1.1Market Composition and Scenario
• 3.2Key Factors Impacting the Market
  • 3.2.1Market Drivers
  • 3.2.2Market Opportunities
  • 3.2.3Market Restraints
  • 3.2.4Market Challenges
• 3.3Porter's Five Forces Analysis

Chapter 4.Recent strategies deployed in Ruminant Vaccines Market

Chapter 5.Global Ruminant Vaccines Market by Animal Type

• 5.1Global Cattle Market by Region
• 5.2Global Sheep & Goats Market by Region

Chapter 6.Global Ruminant Vaccines Market by Vaccines Type

• 6.1Global Modified/ Attenuated Live Market by Region
• 6.2Global Inactivated (Killed) Market by Region
• 6.3Global Others Market by Region

Chapter 7.Global Ruminant Vaccines Market by Route of Administration

• 7.1Global Injectable Market by Region
• 7.2Global Intranasal Market by Region

Chapter 8.Global Ruminant Vaccines Market by Indication

• 8.1Global Bovine Respiratory Diseases (BRD) Market by Region
• 8.2Global Diarrhea/ Scours Market by Region
• 8.3Global FMD Market by Region
• 8.4Global Clostridial Diseases Market by Region
• 8.5Global Leptospirosis Market by Region
• 8.6Global BVD Infection Market by Region
• 8.7Global Others Market by Region

Chapter 9.Global Ruminant Vaccines Market by Region

• 9.1North America Ruminant Vaccines Market
  • 9.1.1North America Ruminant Vaccines Market by Animal Type
    • 9.1.1.1North America Cattle Market by Country
    • 9.1.1.2North America Sheep & Goats Market by Country
  • 9.1.2North America Ruminant Vaccines Market by Vaccines Type
    • 9.1.2.1North America Modified/ Attenuated Live Market by Country
    • 9.1.2.2North America Inactivated (Killed) Market by Country
    • 9.1.2.3North America Others Market by Country
  • 9.1.3North America Ruminant Vaccines Market by Route of Administration
    • 9.1.3.1North America Injectable Market by Country
    • 9.1.3.2North America Intranasal Market by Country
  • 9.1.4North America Ruminant Vaccines Market by Indication
    • 9.1.4.1North America Bovine Respiratory Diseases (BRD) Market by Country
    • 9.1.4.2North America Diarrhea/ Scours Market by Country
    • 9.1.4.3North America FMD Market by Country
    • 9.1.4.4North America Clostridial Diseases Market by Country
    • 9.1.4.5North America Leptospirosis Market by Country
    • 9.1.4.6North America BVD Infection Market by Country
    • 9.1.4.7North America Others Market by Country
  • 9.1.5North America Ruminant Vaccines Market by Country
    • 9.1.5.1US Ruminant Vaccines Market
      • 9.1.5.1.1US Ruminant Vaccines Market by Animal Type
      • 9.1.5.1.2US Ruminant Vaccines Market by Vaccines Type
      • 9.1.5.1.3US Ruminant Vaccines Market by Route of Administration
      • 9.1.5.1.4US Ruminant Vaccines Market by Indication
    • 9.1.5.2Canada Ruminant Vaccines Market
      • 9.1.5.2.1Canada Ruminant Vaccines Market by Animal Type
      • 9.1.5.2.2Canada Ruminant Vaccines Market by Vaccines Type
      • 9.1.5.2.3Canada Ruminant Vaccines Market by Route of Administration
      • 9.1.5.2.4Canada Ruminant Vaccines Market by Indication
    • 9.1.5.3Mexico Ruminant Vaccines Market
      • 9.1.5.3.1Mexico Ruminant Vaccines Market by Animal Type
      • 9.1.5.3.2Mexico Ruminant Vaccines Market by Vaccines Type
      • 9.1.5.3.3Mexico Ruminant Vaccines Market by Route of Administration
      • 9.1.5.3.4Mexico Ruminant Vaccines Market by Indication
    • 9.1.5.4Rest of North America Ruminant Vaccines Market
      • 9.1.5.4.1Rest of North America Ruminant Vaccines Market by Animal Type
      • 9.1.5.4.2Rest of North America Ruminant Vaccines Market by Vaccines Type
      • 9.1.5.4.3Rest of North America Ruminant Vaccines Market by Route of Administration
      • 9.1.5.4.4Rest of North America Ruminant Vaccines Market by Indication
• 9.2Europe Ruminant Vaccines Market
  • 9.2.1Europe Ruminant Vaccines Market by Animal Type
    • 9.2.1.1Europe Cattle Market by Country
    • 9.2.1.2Europe Sheep & Goats Market by Country
  • 9.2.2Europe Ruminant Vaccines Market by Vaccines Type
    • 9.2.2.1Europe Modified/ Attenuated Live Market by Country
    • 9.2.2.2Europe Inactivated (Killed) Market by Country
    • 9.2.2.3Europe Others Market by Country
  • 9.2.3Europe Ruminant Vaccines Market by Route of Administration
    • 9.2.3.1Europe Injectable Market by Country
    • 9.2.3.2Europe Intranasal Market by Country
  • 9.2.4Europe Ruminant Vaccines Market by Indication
    • 9.2.4.1Europe Bovine Respiratory Diseases (BRD) Market by Country
    • 9.2.4.2Europe Diarrhea/ Scours Market by Country
    • 9.2.4.3Europe FMD Market by Country
    • 9.2.4.4Europe Clostridial Diseases Market by Country
    • 9.2.4.5Europe Leptospirosis Market by Country
    • 9.2.4.6Europe BVD Infection Market by Country
    • 9.2.4.7Europe Others Market by Country
  • 9.2.5Europe Ruminant Vaccines Market by Country
    • 9.2.5.1Germany Ruminant Vaccines Market
      • 9.2.5.1.1Germany Ruminant Vaccines Market by Animal Type
      • 9.2.5.1.2Germany Ruminant Vaccines Market by Vaccines Type
      • 9.2.5.1.3Germany Ruminant Vaccines Market by Route of Administration
      • 9.2.5.1.4Germany Ruminant Vaccines Market by Indication
    • 9.2.5.2UK Ruminant Vaccines Market
      • 9.2.5.2.1UK Ruminant Vaccines Market by Animal Type
      • 9.2.5.2.2UK Ruminant Vaccines Market by Vaccines Type
      • 9.2.5.2.3UK Ruminant Vaccines Market by Route of Administration
      • 9.2.5.2.4UK Ruminant Vaccines Market by Indication
    • 9.2.5.3France Ruminant Vaccines Market
      • 9.2.5.3.1France Ruminant Vaccines Market by Animal Type
      • 9.2.5.3.2France Ruminant Vaccines Market by Vaccines Type
      • 9.2.5.3.3France Ruminant Vaccines Market by Route of Administration
      • 9.2.5.3.4France Ruminant Vaccines Market by Indication
    • 9.2.5.4Russia Ruminant Vaccines Market
      • 9.2.5.4.1Russia Ruminant Vaccines Market by Animal Type
      • 9.2.5.4.2Russia Ruminant Vaccines Market by Vaccines Type
      • 9.2.5.4.3Russia Ruminant Vaccines Market by Route of Administration
      • 9.2.5.4.4Russia Ruminant Vaccines Market by Indication
    • 9.2.5.5Spain Ruminant Vaccines Market
      • 9.2.5.5.1Spain Ruminant Vaccines Market by Animal Type
      • 9.2.5.5.2Spain Ruminant Vaccines Market by Vaccines Type
      • 9.2.5.5.3Spain Ruminant Vaccines Market by Route of Administration
      • 9.2.5.5.4Spain Ruminant Vaccines Market by Indication
    • 9.2.5.6Italy Ruminant Vaccines Market
      • 9.2.5.6.1Italy Ruminant Vaccines Market by Animal Type
      • 9.2.5.6.2Italy Ruminant Vaccines Market by Vaccines Type
      • 9.2.5.6.3Italy Ruminant Vaccines Market by Route of Administration
      • 9.2.5.6.4Italy Ruminant Vaccines Market by Indication
    • 9.2.5.7Rest of Europe Ruminant Vaccines Market
      • 9.2.5.7.1Rest of Europe Ruminant Vaccines Market by Animal Type
      • 9.2.5.7.2Rest of Europe Ruminant Vaccines Market by Vaccines Type
      • 9.2.5.7.3Rest of Europe Ruminant Vaccines Market by Route of Administration
      • 9.2.5.7.4Rest of Europe Ruminant Vaccines Market by Indication
• 9.3Asia Pacific Ruminant Vaccines Market
  • 9.3.1Asia Pacific Ruminant Vaccines Market by Animal Type
    • 9.3.1.1Asia Pacific Cattle Market by Country
    • 9.3.1.2Asia Pacific Sheep & Goats Market by Country
  • 9.3.2Asia Pacific Ruminant Vaccines Market by Vaccines Type
    • 9.3.2.1Asia Pacific Modified/ Attenuated Live Market by Country
    • 9.3.2.2Asia Pacific Inactivated (Killed) Market by Country
    • 9.3.2.3Asia Pacific Others Market by Country
  • 9.3.3Asia Pacific Ruminant Vaccines Market by Route of Administration
    • 9.3.3.1Asia Pacific Injectable Market by Country
    • 9.3.3.2Asia Pacific Intranasal Market by Country
  • 9.3.4Asia Pacific Ruminant Vaccines Market by Indication
    • 9.3.4.1Asia Pacific Bovine Respiratory Diseases (BRD) Market by Country
    • 9.3.4.2Asia Pacific Diarrhea/ Scours Market by Country
    • 9.3.4.3Asia Pacific FMD Market by Country
    • 9.3.4.4Asia Pacific Clostridial Diseases Market by Country
    • 9.3.4.5Asia Pacific Leptospirosis Market by Country
    • 9.3.4.6Asia Pacific BVD Infection Market by Country
    • 9.3.4.7Asia Pacific Others Market by Country
  • 9.3.5Asia Pacific Ruminant Vaccines Market by Country
    • 9.3.5.1China Ruminant Vaccines Market
      • 9.3.5.1.1China Ruminant Vaccines Market by Animal Type
      • 9.3.5.1.2China Ruminant Vaccines Market by Vaccines Type
      • 9.3.5.1.3China Ruminant Vaccines Market by Route of Administration
      • 9.3.5.1.4China Ruminant Vaccines Market by Indication
    • 9.3.5.2Japan Ruminant Vaccines Market
      • 9.3.5.2.1Japan Ruminant Vaccines Market by Animal Type
      • 9.3.5.2.2Japan Ruminant Vaccines Market by Vaccines Type
      • 9.3.5.2.3Japan Ruminant Vaccines Market by Route of Administration
      • 9.3.5.2.4Japan Ruminant Vaccines Market by Indication
    • 9.3.5.3India Ruminant Vaccines Market
      • 9.3.5.3.1India Ruminant Vaccines Market by Animal Type
      • 9.3.5.3.2India Ruminant Vaccines Market by Vaccines Type
      • 9.3.5.3.3India Ruminant Vaccines Market by Route of Administration
      • 9.3.5.3.4India Ruminant Vaccines Market by Indication
    • 9.3.5.4South Korea Ruminant Vaccines Market
      • 9.3.5.4.1South Korea Ruminant Vaccines Market by Animal Type
      • 9.3.5.4.2South Korea Ruminant Vaccines Market by Vaccines Type
      • 9.3.5.4.3South Korea Ruminant Vaccines Market by Route of Administration
      • 9.3.5.4.4South Korea Ruminant Vaccines Market by Indication
    • 9.3.5.5Australia Ruminant Vaccines Market
      • 9.3.5.5.1Australia Ruminant Vaccines Market by Animal Type
      • 9.3.5.5.2Australia Ruminant Vaccines Market by Vaccines Type
      • 9.3.5.5.3Australia Ruminant Vaccines Market by Route of Administration
      • 9.3.5.5.4Australia Ruminant Vaccines Market by Indication
    • 9.3.5.6Malaysia Ruminant Vaccines Market
      • 9.3.5.6.1Malaysia Ruminant Vaccines Market by Animal Type
      • 9.3.5.6.2Malaysia Ruminant Vaccines Market by Vaccines Type
      • 9.3.5.6.3Malaysia Ruminant Vaccines Market by Route of Administration
      • 9.3.5.6.4Malaysia Ruminant Vaccines Market by Indication
    • 9.3.5.7Rest of Asia Pacific Ruminant Vaccines Market
      • 9.3.5.7.1Rest of Asia Pacific Ruminant Vaccines Market by Animal Type
      • 9.3.5.7.2Rest of Asia Pacific Ruminant Vaccines Market by Vaccines Type
      • 9.3.5.7.3Rest of Asia Pacific Ruminant Vaccines Market by Route of Administration
      • 9.3.5.7.4Rest of Asia Pacific Ruminant Vaccines Market by Indication
• 9.4LAMEA Ruminant Vaccines Market
  • 9.4.1LAMEA Ruminant Vaccines Market by Animal Type
    • 9.4.1.1LAMEA Cattle Market by Country
    • 9.4.1.2LAMEA Sheep & Goats Market by Country
  • 9.4.2LAMEA Ruminant Vaccines Market by Vaccines Type
    • 9.4.2.1LAMEA Modified/ Attenuated Live Market by Country
    • 9.4.2.2LAMEA Inactivated (Killed) Market by Country
    • 9.4.2.3LAMEA Others Market by Country
  • 9.4.3LAMEA Ruminant Vaccines Market by Route of Administration
    • 9.4.3.1LAMEA Injectable Market by Country
    • 9.4.3.2LAMEA Intranasal Market by Country
  • 9.4.4LAMEA Ruminant Vaccines Market by Indication
    • 9.4.4.1LAMEA Bovine Respiratory Diseases (BRD) Market by Country
    • 9.4.4.2LAMEA Diarrhea/ Scours Market by Country
    • 9.4.4.3LAMEA FMD Market by Country
    • 9.4.4.4LAMEA Clostridial Diseases Market by Country
    • 9.4.4.5LAMEA Leptospirosis Market by Country
    • 9.4.4.6LAMEA BVD Infection Market by Country
    • 9.4.4.7LAMEA Others Market by Country
  • 9.4.5LAMEA Ruminant Vaccines Market by Country
    • 9.4.5.1Brazil Ruminant Vaccines Market
      • 9.4.5.1.1Brazil Ruminant Vaccines Market by Animal Type
      • 9.4.5.1.2Brazil Ruminant Vaccines Market by Vaccines Type
      • 9.4.5.1.3Brazil Ruminant Vaccines Market by Route of Administration
      • 9.4.5.1.4Brazil Ruminant Vaccines Market by Indication
    • 9.4.5.2Argentina Ruminant Vaccines Market
      • 9.4.5.2.1Argentina Ruminant Vaccines Market by Animal Type
      • 9.4.5.2.2Argentina Ruminant Vaccines Market by Vaccines Type
      • 9.4.5.2.3Argentina Ruminant Vaccines Market by Route of Administration
      • 9.4.5.2.4Argentina Ruminant Vaccines Market by Indication
    • 9.4.5.3UAE Ruminant Vaccines Market
      • 9.4.5.3.1UAE Ruminant Vaccines Market by Animal Type
      • 9.4.5.3.2UAE Ruminant Vaccines Market by Vaccines Type
      • 9.4.5.3.3UAE Ruminant Vaccines Market by Route of Administration
      • 9.4.5.3.4UAE Ruminant Vaccines Market by Indication
    • 9.4.5.4Saudi Arabia Ruminant Vaccines Market
      • 9.4.5.4.1Saudi Arabia Ruminant Vaccines Market by Animal Type
      • 9.4.5.4.2Saudi Arabia Ruminant Vaccines Market by Vaccines Type
      • 9.4.5.4.3Saudi Arabia Ruminant Vaccines Market by Route of Administration
      • 9.4.5.4.4Saudi Arabia Ruminant Vaccines Market by Indication
    • 9.4.5.5South Africa Ruminant Vaccines Market
      • 9.4.5.5.1South Africa Ruminant Vaccines Market by Animal Type
      • 9.4.5.5.2South Africa Ruminant Vaccines Market by Vaccines Type
      • 9.4.5.5.3South Africa Ruminant Vaccines Market by Route of Administration
      • 9.4.5.5.4South Africa Ruminant Vaccines Market by Indication
    • 9.4.5.6Nigeria Ruminant Vaccines Market
      • 9.4.5.6.1Nigeria Ruminant Vaccines Market by Animal Type
      • 9.4.5.6.2Nigeria Ruminant Vaccines Market by Vaccines Type
      • 9.4.5.6.3Nigeria Ruminant Vaccines Market by Route of Administration
      • 9.4.5.6.4Nigeria Ruminant Vaccines Market by Indication
    • 9.4.5.7Rest of LAMEA Ruminant Vaccines Market
      • 9.4.5.7.1Rest of LAMEA Ruminant Vaccines Market by Animal Type
      • 9.4.5.7.2Rest of LAMEA Ruminant Vaccines Market by Vaccines Type
      • 9.4.5.7.3Rest of LAMEA Ruminant Vaccines Market by Route of Administration
      • 9.4.5.7.4Rest of LAMEA Ruminant Vaccines Market by Indication

Chapter 10.Company Profiles

• 10.1Boehringer Ingelheim International GmbH
  • 10.1.1Company Overview
  • 10.1.2Financial Analysis
  • 10.1.3Regional & Segmental Analysis
  • 10.1.4Research & Development Expenses
  • 10.1.5Recent strategies and developments:
    • 10.1.5.1Partnerships, Collaborations, and Agreements:
    • 10.1.5.2Product Launches and Product Expansions:
    • 10.1.5.3Geographical Expansions:
  • 10.1.6SWOT Analysis
• 10.2Zoetis, Inc.
  • 10.2.1Company Overview
  • 10.2.2Financial Analysis
  • 10.2.3Regional Analysis
  • 10.2.4Research & Development Expenses
  • 10.2.5Recent strategies and developments:
    • 10.2.5.1Product Launches and Product Expansions:
  • 10.2.6SWOT Analysis
• 10.3Merck & Co., Inc.
  • 10.3.1Company Overview
  • 10.3.2Financial Analysis
  • 10.3.3Segmental and Regional Analysis
  • 10.3.4Research & Development Expenses
  • 10.3.5Recent strategies and developments:
    • 10.3.5.1Product Launches and Product Expansions:
  • 10.3.6SWOT Analysis
• 10.4Bimeda, Inc.
  • 10.4.1Company Overview
  • 10.4.2SWOT Analysis
• 10.5Elanco Animal Health, Inc.
  • 10.5.1Company Overview
  • 10.5.2Financial Analysis
  • 10.5.3Regional Analysis
  • 10.5.4Research & Development Expenses
  • 10.5.5SWOT Analysis
• 10.6Virbac
  • 10.6.1Company Overview
  • 10.6.2Financial Analysis
  • 10.6.3Regional Analysis
  • 10.6.4SWOT Analysis
• 10.7Ceva Sante Animale
  • 10.7.1Company Overview
  • 10.7.2Recent strategies and developments:
    • 10.7.2.1Acquisition and Mergers:
  • 10.7.3SWOT Analysis
• 10.8CZ Vaccines S.A.U. (Zendal Health S.A.)
  • 10.8.1Company Overview
  • 10.8.2SWOT Analysis
• 10.9Indian Immunologicals Ltd. (National Dairy Development Board)
  • 10.9.1Company Overview
  • 10.9.2Financial Analysis
  • 10.9.3Research & Development Expenses
  • 10.9.4SWOT Analysis
• 10.10.Vaxxinova International BV (EW Group)
  • 10.10.1Company Overview
  • 10.10.2SWOT Analysis

Chapter 11.Winning strategies of Ruminant Vaccines Market